Gastrointestinal Diseases  >>  pioglitazone  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00926016: Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Completed
N/A
23
US
Pioglitazone (Actos)
Brooke Army Medical Center, The Geneva Foundation
Chronic Hepatitis C
03/10
09/10
NCT01289639: Insulin Resistance in Non-alcoholic Fatty Liver Disease

Terminated
N/A
11
US
fenofibrate, micronized fenofibrate, pioglitazone, Actos, placebo
VA Office of Research and Development
Fatty Liver
08/13
08/14
NCT02475499: Incretin-based Drugs and Pancreatic Cancer

Completed
N/A
886172
Canada
DPP-4 inhibitors, incretin-based drugs, sitagliptin, vildagliptin, saxagliptin, GLP-1 analogs, exenatide, liraglutide, Sulfonylureas, oral hypoglycemic agent, glibenclamide, chlorpropamide, tolbutamide, glibornuride, tolazamide, carbutamide, glipizide, gliquidone, gliclazide, metahexamide, glisoxepide, glimepiride, acetohexamide, glymidine, Biguanides, phenformin, metformin, buformin, Thiazolidinediones, troglitazone, rosiglitazone, pioglitazone, Alpha-glucosidase inhibitors, acarbose, miglitol, voglibose, Meglitinides, repaglinide, nateglinide
Canadian Network for Observational Drug Effect Studies, CNODES, Drug Safety and Effectiveness Network, Canada, Canadian Institutes of Health Research (CIHR)
Diabetes Mellitus, Type 2
04/15
04/15
NCT02476760: Incretin-based Drugs and Acute Pancreatitis

Completed
N/A
1417914
Canada
DPP-4 inhibitors, incretin-based drugs, sitagliptin, vildagliptin, saxagliptin, GLP-1 analogs, exenatide, liraglutide, Insulins, insulins and analogues for injection, fast-acting, insulins and analogues for injection, intermediate-acting, insulins and analogues for injection, long-acting, insulins and analogues for inhalation, Biguanides, oral hypoglycemic agent, phenformin, metformin, buformin, Sulfonylureas, glibenclamide, chlorpropamide, tolbutamide, glibornuride, tolazamide, carbutamide, glipizide, gliquidone, gliclazide, metahexamide, glisoxepide, glimepiride, acetohexamide, glymidine, Thiazolidinediones, troglitazone, rosiglitazone, pioglitazone, Alpha-glucosidase inhibitors, acarbose, miglitol, voglibose, Meglitinides, repaglinide, nateglinide
Canadian Network for Observational Drug Effect Studies, CNODES, Drug Safety and Effectiveness Network, Canada, Canadian Institutes of Health Research (CIHR)
Diabetes Mellitus, Type 2
04/15
04/15

Download Options